Fly News Breaks for February 27, 2015
PCYC
Feb 27, 2015 | 06:56 EDT
Credit Suisse downgraded Pharmacyclics to Neutral citing valuation following reports of a possible acquisition in the $17B-$18B range.
News For PCYC From the Last 2 Days
There are no results for your query PCYC